Patents by Inventor Michael R. Palovich

Michael R. Palovich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
    Publication number: 20160002220
    Abstract: Methods of using Muscarinic Acetylcholine Receptor Antagonists are provided.
    Type: Application
    Filed: September 10, 2015
    Publication date: January 7, 2016
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • Cathepsin C inhibitors
    Patent number: 9187461
    Abstract: Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: November 17, 2015
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Christopher E. Neipp, Michael R. Palovich
  • Muscarinic acetylcholine receptor antagonists
    Patent number: 9144571
    Abstract: Methods of using Muscarinic Acetylcholine Receptor Antagonists are provided.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: September 29, 2015
    Assignee: Glaxo Group Limited
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
    Publication number: 20150238470
    Abstract: Methods of using Muscarinic Acetylcholine Receptor Antagonists are provided.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • Muscarinic acetylcholine receptor antagonists
    Patent number: 9045469
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: June 2, 2015
    Assignee: Glaxo Group Limited
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
    Publication number: 20140371264
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Application
    Filed: September 4, 2014
    Publication date: December 18, 2014
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • CATHEPSIN C INHIBITORS
    Publication number: 20140364476
    Abstract: Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: August 21, 2014
    Publication date: December 11, 2014
    Inventors: Christopher E. NEIPP, Michael R. PALOVICH
  • Muscarinic acetylcholine receptor antagonists
    Patent number: 8853404
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: October 7, 2014
    Assignee: Glaxo Group Limited
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • Cathepsin C inhibitors
    Patent number: 8841463
    Abstract: Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: September 23, 2014
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Christopher E Neipp, Michael R. Palovich
  • MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
    Publication number: 20140080863
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Application
    Filed: October 14, 2013
    Publication date: March 20, 2014
    Applicant: Glaxo Group Limited
    Inventors: Dramane Ibrahim LAINE, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • CATHEPSIN C INHIBITORS
    Publication number: 20130324584
    Abstract: Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: February 9, 2012
    Publication date: December 5, 2013
    Inventors: Christopher E. Neipp, Michael R. Palovich
  • Muscarinic acetylcholine receptor antagonists
    Patent number: 8575347
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: November 5, 2013
    Assignee: Glaxo Group Limited
    Inventors: Dramane Ibrahim Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
    Publication number: 20130030015
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Application
    Filed: September 26, 2012
    Publication date: January 31, 2013
    Applicant: Glaxo Group Limited
    Inventors: Dramane I. LAINE, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • Muscarinic acetylcholine receptor antagonists
    Patent number: 8309572
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: November 13, 2012
    Assignee: Glaxo Group Limited
    Inventors: Dramane I. Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
    Publication number: 20120157491
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Application
    Filed: February 22, 2012
    Publication date: June 21, 2012
    Applicant: Glaxo Group Limited
    Inventors: Dramane I. Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • CATHEPSIN C INHIBITORS
    Publication number: 20120142668
    Abstract: Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 7, 2012
    Inventors: Niall Anderson, Ann M. Bullion, Neysa Nevins, Michael R. Palovich, Steven L. Sollis, Michael D. Wall, Jakob Busch-Petersen, Brian Evans, Huijie Li
  • Muscarinic acetylcholine receptor antagonists
    Patent number: 8183257
    Abstract: Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: May 22, 2012
    Assignee: Glaxo Group Limited
    Inventors: Dramane I. Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
  • Mmuscarinic acetylcholine receptor antagonists
    Patent number: 7932247
    Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
    Type: Grant
    Filed: November 15, 2005
    Date of Patent: April 26, 2011
    Assignee: Glaxo Group Limited
    Inventors: Brian W. Budzik, Anthony W. J. Cooper, Jian Jin, Dramane I. Laine, Brent W. McCleland, Michael R. Palovich, Ralph A. Rivero, Yonghui Wang, Haibo Xie, Chongjie Zhu
  • M3 muscarinic acetylcholine receptor antagonists
    Patent number: 7906531
    Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
    Type: Grant
    Filed: July 16, 2009
    Date of Patent: March 15, 2011
    Assignee: Glaxo Group Limited
    Inventors: Zehong Wan, Hongxing Yan, Michael R. Palovich, Dramane I. Laine
  • METHOD OF TREATMENT
    Publication number: 20100256157
    Abstract: This invention relates to the use of a sulfonamide substituted diphenyl urea compound to treat cystic fibrosis, or the symptoms associated with cystic fibrosis.
    Type: Application
    Filed: March 19, 2010
    Publication date: October 7, 2010
    Inventors: Jakob Busch-Petersen, Thomas B. LEONARD, Michael R. Palovich, Henry M. Sarau, Aili L. Lazaar, Katherine L. Widdowson